Introduction: Canine mammary gland tumor is the most common type of neoplasia in non-ovariectomized bitches. Approximately 50% of tumors are malignant. Neoplasms originating from the mammary gland represent the most common neoplastic disease in canines in Veterinary Medicine. Aim: Relate the expression of the receptor to progesterone (PR) with the tumor stage of canine mammary carcinoma. Material and Methods: Analytical-cross-sectional study, samples of paraffinized tumor tissue obtained from 30 canine patients with breast cancer were used. The expression of PR was performed by immunohistochemical labeling, using murine anti-PR (anti-PR Biocare brand). A descriptive analysis was carried out with the results using the SPSS program. Results: The predominant histological subtype of breast cancer was tubular carcinoma with 12 patients, followed by papillary cystic carcinoma with 6 patients, solid carcinoma 5, carcinosarcoma 4 and comedocarcinoma 3. There was a significant trend between breast cancer subtypes, histological grade G1. Among the histopathological findings, the degree of invasion is related to the presence of tumor cells in adjacent lymph nodes, which is why it is a prognostic indicator. The expression of PR in the tumor tissue samples it was 42.8% positive versus 57.14% negative, of which 75% correspond to G1, 8.3% to G2 and 16.6% to G3. With respect to the relationship of the expression of PR vs type of tumor, it was found that 50% correspond to tubular carcinoma, 33.3% to papillary cystic carcinoma, 8.3% to solid carcinoma and 8.3% to comedocarcinoma. Conclusion: The hormone receptor was negative in more than half of the patients and histological grade is significantly associated with tumor subtypes, this study emphasizes the need to introduce receptor testing into our routine clinical practice to offer the best treatment for breast cancer.
References
[1]
Peña, L., Gama, A., Goldschmidt, M.H., Abadie, J., Benazzi, C., Castagnaro, M., et al. (2013) Canine Mammary Tumors. Veterinary Pathology, 51, 127-145. https://doi.org/10.1177/0300985813509388
[2]
Rasotto, R., Berlato, D., Goldschmidt, M.H. and Zappulli, V. (2017) Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases. Veterinary Pathology, 54, 571-578. https://doi.org/10.1177/0300985817698208
[3]
Sanchez, F. (2005) Incidence, Classification and Therapy of Mammary Tumors in Canines. Master’s Thesis, Pedagogical and Technological University of Colombia.
[4]
Kim, T., Yang, I.S., Seung, B., Lee, S., Kim, D., Ha, Y., et al. (2020) Cross-Species Oncogenic Signatures of Breast Cancer in Canine Mammary Tumors. Nature Communications, 11, Article No. 3616. https://doi.org/10.1038/s41467-020-17458-0
[5]
Canadas, A., França, M., Pereira, C., Vilaça, R., Vilhena, H., Tinoco, F., et al. (2018) Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study. Veterinary Pathology, 56, 208-219. https://doi.org/10.1177/0300985818806968
[6]
Jaillardon, L., Abadie, J., Godard, T., Campone, M., Loussouarn, D., Siliart, B., et al. (2015) The Dog as a Naturally-Occurring Model for Insulin-Like Growth Factor Type 1 Receptor-Overexpressing Breast Cancer: An Observational Cohort Study. BMC Cancer, 15, Article No. 664. https://doi.org/10.1186/s12885-015-1670-6
[7]
Seung, B., Cho, S., Kim, S., Bae, M., Lim, H., Kwak, S., et al. (2021) Impact of Histological Subtype on Survival in Canine Mammary Carcinomas: A Retrospective Analysis of 155 Cases. Journal of Comparative Pathology, 186, 23-30. https://doi.org/10.1016/j.jcpa.2021.05.002
[8]
Alenza, D.P., Rutteman, G.R., Peña, L., Beynen, A.C. and Cuesta, P. (1998) Relation between Habitual Diet and Canine Mammary Tumors in a Case-Control Study. Journal of Veterinary Internal Medicine, 12, 132-139. https://doi.org/10.1111/j.1939-1676.1998.tb02108.x
[9]
Shafiee, R., Javanbakht, J., Atyabi, N., Kheradmand, P., Kheradmand, D., Bahrami, A., et al. (2013) RETRACTED ARTICLE: Diagnosis, Classification and Grading of Canine Mammary Tumours as a Model to Study Human Breast Cancer: An Clinico-Cytohistopathological Study with Environmental Factors Influencing Public Health and Medicine. Cancer Cell International, 13, Article No. 469. https://doi.org/10.1186/1475-2867-13-79
[10]
Toniti, W., Buranasinsup, S., Kongcharoen, A., Charoonrut, P., Puchadapirom, P. and Kasorndorkbua, C. (2009) Immunohistochemical Determination of Estrogen and Progesterone Receptors in Canine Mammary Tumors. Asian Pacific Journal of Cancer Prevention, 10, 907-911.
[11]
Liu, D., Xiong, H., Ellis, A.E., Northrup, N.C., Rodriguez, C.O., O’Regan, R.M., et al. (2014) Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer. Cancer Research, 74, 5045-5056. https://doi.org/10.1158/0008-5472.can-14-0392
[12]
Sorenmo, K.U., Rasotto, R., Zappulli, V. and Goldschmidt, M.H. (2010) Development, Anatomy, Histology, Lymphatic Drainage, Clinical Features, and Cell Differentiation Markers of Canine Mammary Gland Neoplasms. Veterinary Pathology, 48, 85-97. https://doi.org/10.1177/0300985810389480
[13]
Owen, L. (1980) TNM Classification of Tumors in Domestic Animals. ED World Health Organization. Organisation mondiale de la Santé.
[14]
Burrai, G.P., Tanca, A., De Miglio, M.R., Abbondio, M., Pisanu, S., Polinas, M., et al. (2015) Investigation of HER2 Expression in Canine Mammary Tumors by Antibody-Based, Transcriptomic and Mass Spectrometry Analysis: Is the Dog a Suitable Animal Model for Human Breast Cancer? Tumor Biology, 36, 9083-9091. https://doi.org/10.1007/s13277-015-3661-2
[15]
Ji, S., Wu, A. and Yang, H. (2012) Expression of Progesterone Receptor Membrane Component 1 Is Associated with Malignant Phenotypes of Breast Cancer. Journal of Southern Medical University, 32, 635-638.
[16]
Kaszak, I., Ruszczak, A., Kanafa, S., Kacprzak, K., Król, M. and Jurka, P. (2018) Current Biomarkers of Canine Mammary Tumors. Acta Veterinaria Scandinavica, 60, Article No. 66. https://doi.org/10.1186/s13028-018-0417-1
